|
Synonyms: GSK-2398852 | GSK2398852
Compound class:
Antibody
Comment: Dezamizumab (GSK2398852) is an anti-human serum amyloid P component (anti-SAP) monoclonal antibody, that was developed by GlaxoSmithKline as a potential therapy for the rare disease amyloidosis.
|
Classification  |
|
| Compound class | Antibody |
| International Nonproprietary Names |
|
| INN number | INN |
| 10364 | dezamizumab |
| Synonyms |
| GSK-2398852 | GSK2398852 |
| Database Links |
|
| Specialist databases | |
| IMGT/mAb-DB | 652 |
| Other databases | |
| GtoPdb PubChem SID | 249565935 |
| Search PubMed clinical trials | dezamizumab |
| Search PubMed titles | dezamizumab |
| Search PubMed titles/abstracts | dezamizumab |
